Skip to main content

Table 3 Multivariate logistic regression model of factors associated with hospital admission

From: Discharge or admit? Emergency department management of incidental pulmonary embolism in patients with cancer: a retrospective study

 

SE

Wald

P

OR

95% CL for OR

Lower

Upper

Age

0.023

4.556

0.033*

1.051

1.004

1.100

Sex

0.518

2.272

0.132

0.458

0.166

1.264

Race (reference: Black)

 

7.688

0.053

   

 Hispanic

0.710

0.194

0.659

0.731

0.182

2.943

 Other

0.997

4.460

0.035

0.122

0.017

0.859

 Non-Hispanic white

2.255

4.147

0.042

0.010

0.000

0.842

Cancer type (liquida vs. solid)

0.950

2.271

0.132

4.188

0.650

26.975

Cancer stage (reference: 0)

 

9.052

0.060

   

 I

40192.970

0.000

>0.999

0.000

0.000

 

 II

1.172

0.722

0.396

0.370

0.037

3.673

 III

1.059

1.657

0.198

0.256

0.032

2.039

 IV

1.319

7.336

0.007

0.028

0.002

0.373

ECOG PS (reference: 0)

 

5.537

0.237

   

 1

19503.505

0.000

0.999

0.000

0.000

 

 2

19503.505

0.000

0.999

0.000

0.000

 

 3

19503.505

0.000

0.999

0.000

0.000

 

 4

19503.505

0.000

0.999

0.000

0.000

 

Charlson comorbidity index (age unadjusted)

0.209

0.308

0.579

0.891

0.592

1.341

Tachycardia (>100 beats/min)

0.643

5.249

0.022*

0.229

0.065

0.808

Hypotension (systolic <100 mmHg)

1.397

2.268

0.132

0.122

0.008

1.886

Tachypnea (>20 breaths/min)

1.402

1.126

0.289

4.427

0.284

69.090

Hypoxemia (oxygen saturation <93%)

1.116

11.110

0.001*

0.024

0.003

0.216

Location of incidental PE (reference: subsegmental)

 

18.526

<0.001*

   

 Segmental

14449.425

0.000

0.999

17913173674.808

0.000

 

 Main/lobar pulmonary artery

0.797

14.731

<0.001*

21.281

4.465

101.428

 Saddle

0.628

1.120

0.290

1.943

0.568

6.645

 Constant

19503.505

0.000

0.999

722285828219.644

  
  1. Abbreviations: CL confidence limit, ECOG PS Eastern Cooperative Oncology Group performance status, OR odds ratio, PE pulmonary embolism, SE standard error
  2. aIncludes multiple myeloma, lymphoma, leukemia, stem cell transplant
  3. *Significant at P < 0.05